Mission
Texas Biomed is the only independent nonprofit infectious disease research institute in the U.S. that combines high-level biocontainment labs for infectious disease and biodefense research, being a federally-designated National Primate Research Center with more than 80 years of discoveries advancing diagnostics, vaccines, and therapies.
Basic Information
Tax-Exempt
Founded in
1941
EIN
74-1109630
Total Assets
$234.6 million
UN Sustainable Development Goals Supported
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Showing 3 of 4 goals
At a Glance
Global Health Symposium 2025
Bringing together leaders to discuss innovations in biomedical science.
Science Gave Them a Future
Impact stories highlighting the role of science in transforming lives.
Research Highlights
Innovative research in infectious diseases.
Impact Stats
2020
Year Achieved
First COVID-19 Vaccine
Advanced the development of the first COVID-19 vaccine.
2014
Year Achieved
First Ebola Treatment
Developed the first treatment for Ebola.
2013
Year Achieved
First Hepatitis-C Therapy
Developed the first therapy for Hepatitis-C.
Upcoming Events
Our Programs
Disease Intervention & Prevention
Focuses on prevention and treatment of infectious diseases.
Learn MoreVolunteer Opportunities
MIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
65
32
/100
Program Expense Ratio
52.92%
4
/20
Program Revenue Growth
-77.65%
2
/20
Leverage Ratio
0.414
10
/20
Working Capital Ratio
1.896
14
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2022
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 55.3M | 85.02% |
| Program Services | 4.929M | 7.58% |
| Investment Income | 1.343M | 2.06% |
| Sales of Non-Inventory Assets | 2.063M | 3.17% |
| Other Notable Sources | 856K | 1.32% |
| Total Revenue | 65.05M | 100.00% |
Related Nonprofits
Scleroderma Foundation of Greater Chicago
Med Research
Medical Conditions ResearchUsher 1f Collaborative Inc.
Med Research
Medical Conditions ResearchSalgi Esophageal Cancer Research Foundation
Med Research
Medical Conditions ResearchAmerican Society for Mohs Histotechnology
Med Research
Medical Conditions ResearchScleroderma Foundation Tri State Chapter Inc.
Med Research
Medical Conditions Research